LLY

1,105.4

+0.57%↑

JNJ

207.08

-0.2%↓

ABBV

227.32

-2.16%↓

UNH

329.95

+1.06%↑

AZN

93.77

+0.73%↑

LLY

1,105.4

+0.57%↑

JNJ

207.08

-0.2%↓

ABBV

227.32

-2.16%↓

UNH

329.95

+1.06%↑

AZN

93.77

+0.73%↑

LLY

1,105.4

+0.57%↑

JNJ

207.08

-0.2%↓

ABBV

227.32

-2.16%↓

UNH

329.95

+1.06%↑

AZN

93.77

+0.73%↑

LLY

1,105.4

+0.57%↑

JNJ

207.08

-0.2%↓

ABBV

227.32

-2.16%↓

UNH

329.95

+1.06%↑

AZN

93.77

+0.73%↑

LLY

1,105.4

+0.57%↑

JNJ

207.08

-0.2%↓

ABBV

227.32

-2.16%↓

UNH

329.95

+1.06%↑

AZN

93.77

+0.73%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Open

SectorHealthcare

35.7 0.56

Buy Sell

Overview

Share price change

24h

Current

Min

34.64

Max

35.73

Key metrics
By Trading Economics
Income	11M 51M
Sales	39M 239M
P/E Sector Avg	11.126 79.874
EPS	1.08
Profit margin	21.242
Employees	268
EBITDA	14M 73M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+30.42% upside

Market Stats
By TradingEconomics
Market Cap	344M 2B
Previous open	35.14
Previous close	35.7

News Sentiment

By Acuity

76%

24%

349 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

25 lis 2025, 16:56 UTC

Earnings

Major Market Movers

Alimentation Couche-Tard Shares Rise as 2Q Same-Store Sales Support Profit Growth

25 lis 2025, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25 lis 2025, 23:47 UTC

Market Talk

Nikkei May Rise After Stock Gains on Wall Street -- Market Talk

25 lis 2025, 22:39 UTC

Market Talk

Global Equities Roundup: Market Talk

25 lis 2025, 22:39 UTC

Market Talk

Vault Accelerates Exposure to Spot Gold Prices by Six Months -- Market Talk

25 lis 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

25 lis 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

25 lis 2025, 21:38 UTC

Earnings

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25 lis 2025, 21:31 UTC

Market Talk

F&P Healthcare's Share Price Jumps on Profit Guidance Upgrade -- Market Talk

25 lis 2025, 21:27 UTC

Earnings

These Stocks Moved the Most Today: Nvidia, AMD, Alphabet, Abercrombie, Kohl's, Novo Nordisk, Symbotic, and More -- Barrons.com

25 lis 2025, 21:20 UTC

Earnings

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25 lis 2025, 21:18 UTC

Earnings

NIO Stock Drops as EV Maker Posts Narrower Loss -- Barrons.com

25 lis 2025, 21:15 UTC

Earnings

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25 lis 2025, 20:16 UTC

Market Talk

U.S. Natural Gas Falls as December Contract Expires -- Market Talk

25 lis 2025, 18:42 UTC

Market Talk

USDA Backs Mexican Retail Expo to Raise Agricultural Exports -- Market Talk

25 lis 2025, 18:25 UTC

Acquisitions, Mergers, Takeovers

S&P Global Completes $1.8 Billion Acquisition Of With Intelligence, Strengthening Its Position As A Leader In Private Markets Data & Analytics >SPGI

25 lis 2025, 17:30 UTC

Market Talk

Mexico Posts Record Foreign Direct Investment for Jan-Sep -- Market Talk

25 lis 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

25 lis 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

25 lis 2025, 16:33 UTC

Acquisitions, Mergers, Takeovers

Eni: Financial Details Weren't Disclosed

25 lis 2025, 16:33 UTC

Acquisitions, Mergers, Takeovers

Eni: Block OFF-5 Covers an Area of About 17,000 Km Sq. in Water Depths

25 lis 2025, 16:32 UTC

Acquisitions, Mergers, Takeovers

Eni: Agreement to Become Effective After Approval of Uruguayan Authorities

25 lis 2025, 16:31 UTC

Acquisitions, Mergers, Takeovers

Eni: Acquisition Is for a 50% Share, Operatorship in Exploration Block OFF-5

25 lis 2025, 16:30 UTC

Acquisitions, Mergers, Takeovers

Eni Acquires From YPF Shares in the Exploration Block OFF-5 Offshore Uruguay

25 lis 2025, 16:23 UTC

Earnings

This Robotics Stock Soars 40% on Earnings. Here's Why. -- Barrons.com

25 lis 2025, 16:12 UTC

Market Talk

Euro Expected to Rise to $1.25 in 2026: Deutsche Bank -- Market Talk

25 lis 2025, 16:11 UTC

Market Talk

Dollar Could Take One Final Leg Lower in Early 2026 -- Market Talk

25 lis 2025, 16:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25 lis 2025, 16:10 UTC

Market Talk

Sterling Could Briefly Rise After Budget -- Market Talk

25 lis 2025, 16:10 UTC

Market Talk

Oil Extends Losses on Ukraine-Russia Peace Deal Hopes -- Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

30.42% upside

12 Months Forecast

Average 46 USD 30.42%

High 62 USD

Low 32 USD

Based on 10 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

349 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.